deferasirox
- Product NDC
- 16714-993
- 11-digit product format
- 167140993
- Labeler code
- 16714
- Product ID
- 16714-993_88a22d31-67ae-48ba-9f29-546743246434
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- deferasirox
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- Northstar Rx LLC.
- Application
- ANDA211383
- Marketing category
- ANDA
- Marketing start
- 2020-03-16
- Marketing end
- 2023-03-31
- Substance
- DEFERASIROX
- Active strength
- 90 mg/1
- Pharmacologic classes
- Cytochrome P450 1A2 Inhibitors [MoA], Cytochrome P450 2C8 Inhibitors [MoA], Cytochrome P450 3A4 Inducers [MoA], Iron Chelating Activity [MoA], Iron Chelator [EPC]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 16714-993-01 | 16714099301 | 30 TABLET, FILM COATED in 1 BOTTLE (16714-993-01) | 2020-03-16 | 2023-03-31 | No | No | Current |